Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 06:07 am Sale |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB Biotech AG | 4,000,000 7.200% |
-30,792 (-0.76%) |
Filing History |
| 2024-02-13 06:06 am Purchase |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BB Biotech AG | 5,046,700 3.100% |
269,138 (+5.63%) |
Filing History |
| 2024-02-13 06:05 am Purchase |
2023-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB Biotech AG | 8,517,839 16.500% |
3,140,000 (+58.39%) |
Filing History |
| 2024-02-13 06:04 am Unchanged |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 7,879,583 17.900% |
0 (Unchanged) |
Filing History |
| 2024-01-24 3:46 pm Purchase |
2024-01-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 9,194,064 5.100% |
5,000,000 (+119.22%) |
Filing History |
| 2024-01-24 3:21 pm Unchanged |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 4,194,064 3.700% |
0 (Unchanged) |
Filing History |
| 2023-02-17 5:23 pm Purchase |
2023-02-09 | 13G | Sage Therapeutics, Inc. SAGE |
BB Biotech AG | 3,100,278 5.200% |
150,000 (+5.08%) |
Filing History |
| 2023-02-14 4:20 pm Sale |
2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BB Biotech AG | 300,000 4.400% |
-191,815 (-39.00%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Generation Bio Co. GBIO |
BB Biotech AG | 3,608,280 6.100% |
-244,900 (-6.36%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 4,194,064 5.700% |
-283,900 (-6.34%) |
Filing History |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
BB Biotech AG | 4,066,200 4.100% |
-68,800 (-1.66%) |
Filing History |
| 2023-02-14 4:17 pm Sale |
2022-12-31 | 13G | Myovant Sciences Ltd. MYOV |
BB Biotech AG | 5,872,639 6.000% |
-249,400 (-4.07%) |
Filing History |
| 2023-02-14 4:16 pm Sale |
2022-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB Biotech AG | 2,950,278 5.000% |
-219,826 (-6.93%) |
Filing History |
| 2023-02-14 4:15 pm Purchase |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BB Biotech AG | 4,777,562 5.400% |
175,000 (+3.80%) |
Filing History |
| 2023-02-14 4:14 pm Purchase |
2022-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB Biotech AG | 5,377,839 14.800% |
1,389,437 (+34.84%) |
Filing History |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
BB Biotech AG | 2,132,725 4.100% |
-142,400 (-6.26%) |
Filing History |
| 2023-02-14 4:13 pm Purchase |
2022-12-31 | 13G | Molecular Templates, Inc. MTEM |
BB Biotech AG | 746,134 19.900% |
26,667 (+3.71%) |
Filing History |
| 2023-02-14 4:12 pm Purchase |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 7,879,583 17.900% |
2,863,769 (+57.09%) |
Filing History |
| 2023-02-14 4:10 pm Sale |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB Biotech AG | 4,030,792 7.300% |
-281,500 (-6.53%) |
Filing History |
| 2023-02-14 4:09 pm Purchase |
2022-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 8,929,963 14.500% |
1,654,399 (+22.74%) |
Filing History |